LIN vs PROF
Linde plc Ordinary Shares (LIN) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. PROF currently screens at market cap $238.7M.
Not investment advice. Open the LIN and PROF stock pages for the full models.
Not investment advice.